| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|
| Profit or loss [abstract] | |||||
| Revenue | |||||
| Cost of goods sold ("COGS") | |||||
| Gross margin | |||||
| Selling, general and administrative expenses ("SG&A") | |||||
| Foreign exchange ("FX") loss | |||||
| Operating income | |||||
| Gain on disposal of PP&E | |||||
| Derecognition and unrealized (loss) gain on redemption options | |||||
| Equity earnings from associates and joint ventures | |||||
| Impairment of goodwill | — | ||||
| Earnings before finance costs and income taxes ("EBIT") | |||||
| Net finance costs | |||||
| Earnings (loss) before income taxes ("EBT") | |||||
| Current income taxes | |||||
| Deferred income taxes | |||||
| Income taxes | |||||
| Net earnings (loss) | |||||
| Items that may be reclassified to profit or loss in subsequent periods | |||||
| Change in fair value of derivatives designated as cash-flow hedges, net of income tax recovery | |||||
| Gain on derivatives designated as cash flow hedges transferred to net earnings (loss), net of income tax expense | |||||
| Unrealized gain (loss) on translation of foreign-denominated debt | — | ||||
| Unrealized gain (loss) on translation of financial statements of foreign operations | |||||
| Other comprehensive income (loss) | |||||
| Total comprehensive income (loss) | |||||
| Earnings (loss) per share - basic | |||||
| Earnings (loss) per share - diluted |